Evidence map›Paper›PMID 27437129›Full record

ArticleIranian Red Crescent medical journal2016

Prevalence of Merkel Cell Polyomavirus in Tehran: An Age-Specific Serological Study.

Rouhollah Vahabpour, Mohammad Reza Aghasadeghi, Mostafa Salehi-Vaziri, Nasir Mohajel, Hossein Keyvani, Maryam Nasimi, Maryam Esghaei, Seyed Hamidreza Monavari

Open access · bronzeAbstract read
In one paragraph

Article in Iranian Red Crescent medical journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Rouhollah VahabpourDepartment of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran.
Mohammad Reza AghasadeghiDepartment of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, IR Iran.
Mostafa Salehi-VaziriDepartment of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran.
Nasir MohajelDepartment of Virology, Pasteur Institute of Iran, Tehran, IR Iran.
Hossein KeyvaniDepartment of Virology, Iran University of Medical Sciences, Tehran, IR Iran.
Maryam NasimiDepartment of Dermatology, Tehran University of Medical Sciences, Tehran, IR Iran.
Maryam EsghaeiDepartment of Virology, Iran University of Medical Sciences, Tehran, IR Iran.
Seyed Hamidreza MonavariDepartment of Virology, Iran University of Medical Sciences, Tehran, IR Iran.
Iran University of Medical Sciences · IRTehran University of Medical Sciences · IRPasteur Institute of Iran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSeveral new types of polyomavirus have been discovered in recent years mainly because of the recent state-of-the-art detection technologies. Among the polyomaviruses, Merkel cell polyomavirus (MCPyV) has attracted the most attention because of its possible role in the etiology of Merkel cell carcinoma, a rare but lethal form of skin cancer.

objectivesThis study aimed to determine age-specific seroprevalence of MCPyV in Tehran. PATIENTS AND

methodsIn this cross-sectional study, we collected 440 serum samples from healthy individuals 2 to 78 years of age who visited the Pasteur Institute's clinic in Tehran, Iran, using a convenience sampling strategy. We developed a virus-like particle-based enzyme-linked immunosorbent assay that uses VP1, the major capsid protein of MCPyV, to detect and quantitate serum antibodies to MCPyV. We compared the prevalence of MCPyV between males and females and across eight age groups.

resultsA total of 255 (57.9%) of the serum samples were MCPyV positive. The seroprevalence in children under 10 years of age was 25%. The seroprevalence increased to 56% over the next decade of life (10 - 19 years of age). The seroprevalence rate in males and females was 56.1% and 59.7% respectively, and a binary logistic regression showed no significant difference between males and females (P = 0.77). However, the prevalence of MCPyV increased with age (P = 0.012).

conclusionsOur results suggest that human exposure to MCPyV occurs throughout life. The MCPyV antibody levels remained high among older adults in our population, consistent with reports from other populations.

Indexed as

Enzyme-Linked Immunosorbet AssayMerkel Cell PolyomavirusVirus-Like Particle

Identifiers

PMID27437129
PMCPMC4939235
OpenAlexW2282091877

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.